Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS

Bart A Mulder; Dirk J van Veldhuisen; Harry J G M Crijns; Michael Böhm; Alain Cohen-Solal; Daphne Babalis; Michael Roughton; Marcus D Flather; Andrew J S Coats; Isabelle C Van Gelder

doi:10.1093/eurjhf/hfs100

Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS

Bart A Mulder, Dirk J van Veldhuisen, Harry J G M Crijns, Michael Böhm, Alain Cohen-Solal, Daphne Babalis, Michael Roughton, Marcus D Flather, Andrew J S Coats, Isabelle C Van Gelder

Research output: Contribution to journal › Article › peer-review

56 Citations (Scopus)

Abstract

Beneficial effects of beta-blockade remain unclear in heart failure patients who have atrial fibrillation (AF), especially in the elderly. We evaluated the effect of nebivolol on cardiovascular outcomes in elderly patients with heart failure and AF.

Original language	English
Pages (from-to)	1171-1178
Number of pages	8
Journal	European Journal of Heart Failure
Volume	14
Issue number	10
DOIs	https://doi.org/10.1093/eurjhf/hfs100
Publication status	Published - Oct 2012

Keywords

Heart Failure
Benzopyrans
Double-Blind Method
Humans
Aged
Adrenergic beta-1 Receptor Antagonists
Hospitalization
Aged, 80 and over
Treatment Outcome
Ethanolamines
Atrial Fibrillation
Female
Male
Stroke Volume

Access to Document

10.1093/eurjhf/hfs100

Cite this

Mulder, B. A., van Veldhuisen, D. J., Crijns, H. J. G. M., Böhm, M., Cohen-Solal, A., Babalis, D., Roughton, M., Flather, M. D., Coats, A. J. S., & Van Gelder, I. C. (2012). Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS. European Journal of Heart Failure, 14(10), 1171-1178. https://doi.org/10.1093/eurjhf/hfs100

@article{b2ec14106b1d41c1bec5486a4044f3ea,

title = "Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS",

abstract = "Beneficial effects of beta-blockade remain unclear in heart failure patients who have atrial fibrillation (AF), especially in the elderly. We evaluated the effect of nebivolol on cardiovascular outcomes in elderly patients with heart failure and AF.",

keywords = "Heart Failure, Benzopyrans, Double-Blind Method, Humans, Aged, Adrenergic beta-1 Receptor Antagonists, Hospitalization, Aged, 80 and over, Treatment Outcome, Ethanolamines, Atrial Fibrillation, Female, Male, Stroke Volume",

author = "Mulder, {Bart A} and {van Veldhuisen}, {Dirk J} and Crijns, {Harry J G M} and Michael B{\"o}hm and Alain Cohen-Solal and Daphne Babalis and Michael Roughton and Flather, {Marcus D} and Coats, {Andrew J S} and {Van Gelder}, {Isabelle C}",

year = "2012",

month = oct,

doi = "10.1093/eurjhf/hfs100",

language = "English",

volume = "14",

pages = "1171--1178",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

number = "10",

}

TY - JOUR

T1 - Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation

T2 - insights from SENIORS

AU - Mulder, Bart A

AU - van Veldhuisen, Dirk J

AU - Crijns, Harry J G M

AU - Böhm, Michael

AU - Cohen-Solal, Alain

AU - Babalis, Daphne

AU - Roughton, Michael

AU - Flather, Marcus D

AU - Coats, Andrew J S

AU - Van Gelder, Isabelle C

PY - 2012/10

Y1 - 2012/10

N2 - Beneficial effects of beta-blockade remain unclear in heart failure patients who have atrial fibrillation (AF), especially in the elderly. We evaluated the effect of nebivolol on cardiovascular outcomes in elderly patients with heart failure and AF.

AB - Beneficial effects of beta-blockade remain unclear in heart failure patients who have atrial fibrillation (AF), especially in the elderly. We evaluated the effect of nebivolol on cardiovascular outcomes in elderly patients with heart failure and AF.

KW - Heart Failure

KW - Benzopyrans

KW - Double-Blind Method

KW - Humans

KW - Aged

KW - Adrenergic beta-1 Receptor Antagonists

KW - Hospitalization

KW - Aged, 80 and over

KW - Treatment Outcome

KW - Ethanolamines

KW - Atrial Fibrillation

KW - Female

KW - Male

KW - Stroke Volume

U2 - 10.1093/eurjhf/hfs100

DO - 10.1093/eurjhf/hfs100

M3 - Article

C2 - 22764183

VL - 14

SP - 1171

EP - 1178

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 10

ER -